Direct Diagnostics utilizes advanced technology to provide actionable recommendations and personalized health solutions. The company sells preventive health tests and offers a data-driven eHealth platform for health monitoring. The platform provides insight into a comprehensive set of values through blood analysis.

The mission is to empower individuals to make decisions about their health, leading to better outcomes and higher quality of life. Direct Diagnostics aims to transform the healthcare system from disease control to disease prevention. Direct Diagnostics originated from Sanquin’s innovation department.

We invested in Direct Diagnostics through 819 Evergreen Fund.